EUVIMEDOpdag EUVIMED
Crossref

Intestinal microbiomics and hepatic metabolomics insights into the potential mechanisms of probiotic Bifidobacterium pseudolongum CCFM1253 preventing acute liver injury in mice

Weiling Guo, Shumao Cui iD, Xin Tang, Yongqiu Yan, Feifei Xiong, Qiuxiang Zhang, Jianxin Zhao, Bingyong Mao iD, Hao Zhang

Journal of the Science of Food and Agriculture · 2023

DOI: 10.1002/jsfa.12665 ↗

At a glance

Journal article in Journal of the Science of Food and Agriculture, 2023. Written by Weiling Guo and 8 co-authors. Institution: State Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi, China. Major MEDLINE topics: Probiotics, Chemical and Drug Induced Liver Injury. Cited 25 times so far (Crossref); 48 references. Funded by: Collaborative Innovation Center of Food Safety and Quality Control in Jiangsu Province, Yongjiang Talent Introduction Programme, Collaborative Innovationcenter of Food Safety and Quality Control in Jiangsu Province.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

BACKGROUND Bifidobacterium pseudolongum is widely exists in mammal gut and its abundance is associated with human and animal health. The present study aimed to investigate the potential mechanisms of B. pseudolongum CCFM1253 on protecting against lipopolysaccharide (LPS)‐induced acute liver injury (ALI) by metagenomic analysis and liver metabolomic profiles. RESULTS Bifidobacterium pseudolongum CCFM1253 preintervention remarkably attenuated the influence of LPS on serum alanine transaminase and aspartate amino transferase activities. B. pseudolongum CCFM1253 preintervention remarkably attenuated the inflammation responses (tumor necrosis factor‐α, interleukin‐1β, and interleukin‐6) and elevated antioxidative enzymes activities [total antioxidant capacity, superoxide dismutase, catalase, and glutathione peroxidase] in ALI mice by intervening in the Nf‐kβ and Nrf2 pathways, respectively. Bifidobacterium pseudolongum CCFM1253 treatment elevated the proportion of Alistipes and Bifidobacterium , and decreased the proportion of uncultured Bacteroidales bacterium , Muribaculum , Parasutterella and Ruminococcaceae UCG‐010 in ALI mice, which were strongly correlated with the inhibition of inflammation responses and oxidative stress. Untargeted liver metabolomics exhibited that the hepatoprotective efficacy of B. pseudolongum CCFM1253 might be achieved by altering liver metabolites‐related riboflavin metabolism, phenylalanine metabolism, alanine, citrate cycle (tricarboxylic acid cycle), and so on. Furthermore, riboflavin exposure could control the contents of malondialdehyde, superoxide dismutase, and catalase in hydrogen peroxide‐treated HepG2 cells. CONCLUSION Bifidobacterium pseudolongum CCFM1253 can effectively alleviate inflammatory response and oxidative stress, and regulate the intestinal microbiota composition and liver metabolism, and elevate the liver riboflavin content in LPS‐treated mice. Therefore, B. pseudolongum CCFM1253 could serves as a potential probiotic to ameliorate the host health. © 2023 Society of Chemical Industry.

Subjects

MeSH terms (MEDLINE)

ProbioticsChemical and Drug Induced Liver InjuryHumansAnimalsMiceCatalaseLipopolysaccharidesBifidobacteriumAntioxidantsLiverMetabolomicsSuperoxide DismutaseInflammationMammals

Author keywords

Bifidobacterium pseudolongumacute liver injuryintestinal microbiotaliver metabolomicsriboflavin

Substances

CatalaseLipopolysaccharidesAntioxidantsSuperoxide Dismutase

Authors and institutions

  • State Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi, China.
  • School of Food Science and Technology, Jiangnan University, Wuxi, China.
  • Ningbo Yuyi Biotechnology Co., Ltd, Ningbo, China.
  • National Engineering Research Center for Functional Food, Jiangnan University, Wuxi, China.

ORCID profiles: Shumao Cui, Bingyong Mao

Funding

  • Collaborative Innovation Center of Food Safety and Quality Control in Jiangsu Province
  • Yongjiang Talent Introduction Programme
  • Collaborative Innovationcenter of Food Safety and Quality Control in Jiangsu Province

Cite

APA

Guo, W., Cui, S., Tang, X., Yan, Y., Xiong, F., Zhang, Q., Zhao, J., Mao, B., & Zhang, H. (2023). Intestinal microbiomics and hepatic metabolomics insights into the potential mechanisms of probiotic Bifidobacterium pseudolongum CCFM1253 preventing acute liver injury in mice. Journal of the Science of Food and Agriculture. https://doi.org/10.1002/jsfa.12665

Vancouver

Guo W, Cui S, Tang X, Yan Y, Xiong F, Zhang Q, et al. Intestinal microbiomics and hepatic metabolomics insights into the potential mechanisms of probiotic Bifidobacterium pseudolongum CCFM1253 preventing acute liver injury in mice. Journal of the Science of Food and Agriculture. 2023. doi:10.1002/jsfa.12665

BibTeX
@article{Guo2023,
  author = {Guo, Weiling and Cui, Shumao and Tang, Xin and Yan, Yongqiu and Xiong, Feifei and Zhang, Qiuxiang and Zhao, Jianxin and Mao, Bingyong and Zhang, Hao},
  title = {Intestinal microbiomics and hepatic metabolomics insights into the potential mechanisms of probiotic Bifidobacterium pseudolongum CCFM1253 preventing acute liver injury in mice},
  journal = {Journal of the Science of Food and Agriculture},
  year = {2023},
  doi = {10.1002/jsfa.12665}
}
Start for free →